Fuse Biotherapeutics
is headquartered in Los Angeles, California. Paul Y Song is the CEO of Fuse Biotherapeutics. Fuse Biotherapeutics has received a total of $17.7M in funding. Fuse Biotherapeutics has 1 followers on Owler. Fuse Biotherapeutics has an estimated revenue of <$1M and an estimate of less <10 employees.Fuse Biotherapeutics
is headquartered in Los Angeles, California. Paul Y Song is the CEO of Fuse Biotherapeutics. Fuse Biotherapeutics has received a total of $17.7M in funding. Fuse Biotherapeutics has 1 followers on Owler. Fuse Biotherapeutics has an estimated revenue of <$1M and an estimate of less <10 employees.
News
Apr 09, 2024
PRcom
Press Release: Fuse Biotherapeutics : FuseBio Presents New Data at AACR: Targeting a Functionally-Selective IL-18 (F-18) to PD-1: A Next Generation Checkpoint Inhibitor with Enhanced Anti-Tumor Activity
Nov 30, 2021
FinSMEs
Fuse Biotherapeutics: Fuse Biotherapeutics Raises $9.5M in Sees Funding
Nov 15, 2021
Newswire
Press Release: Fuse Biotherapeutics : Fuse Biotherapeutics Raises an Oversubscribed and Upsized Seed Financing Round of $9.5 Million